Primemd Inc (PRMD) Fair Value & Analysis
Healthcare · US · Market cap $20.3K
Primemd Inc
PRMD · US
Fair value as of: Jun 26, 2026
From 24 valuation models · updated 7 days ago
Fair value updated Jun 26, 2026 — revised from $3.09 to $0.0011 (−100.0%) since Jun 24, 2026.
Price vs Fair Value (12 months)
12‑month range $0.0003 – $0.0011 · fair‑value band $0.0011 – $0.0011 · the $0.0011 price screens above the $0.0011 fair value. As of Jun 26, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Primemd Inc (PRMD) currently trades at $0.0011, while our model-based Fair Value estimate is $0.0011 — implying the stock looks roughly 0.2% overvalued today. We read business quality at 68/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
Trailing-twelve-month revenue stands at $70.0K. Revenue declined 57.8% year over year. It earns a return on equity of -6.9%. Net debt stands at $4.5M. Fundamentals as of Jun 26, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
About the company
Primemd Inc., together with its subsidiaries, is engaged in the purchase and development of residential and commercial real estate properties in the United States. It also holds interests in oil and gas properties. The company was formerly known as Eagle Exploration Co. and changed its name to Primemd Inc. in June 2021. The company is based in Littleton, Colorado.
Revenue & earnings trend
FY2004 – FY2021 · reported fiscal years
Primemd Inc reported revenue of $10.5M in FY2021 versus $39.1K in FY2004, a compound +39.0%/yr. Reported net income was $3.1M in FY2021.
Is PRMD fairly valued? → Check now
Similar stocks
6 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$96.00 | R$25.67 | -73% |
| Fresenius SE FSNUY | $11.30 | $8.61 | -24% |
| Q0F Q0F | 2.76 SGD | 1.28 SGD | -54% |
| 5225 5225 | 8.67 MYR | 3.08 MYR | -64% |
| IHHHF IHHHF | $1.71 | $0.7400 | -57% |
| Rede D'Or São Luiz S.A RDOR3 | R$32.76 | R$30.33 | -7% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Primemd Inc (PRMD) undervalued?
What is the fair value of PRMD?
What is the quality score of PRMD?
What is the revenue of Primemd Inc (PRMD)?
What is the net profit margin of PRMD?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.